Publications (1)4.55 Total impact
-
Article: Erlotinib in symptomatic brain metastases from a lung adenocarcinoma with a sensitizing EGFR mutation.
Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 06/2012; 7(6):1059-60. · 4.55 Impact Factor